Susan Duggan
Chief Operating Officer at TRANSCODE THERAPEUTICS, INC.
Profile
Susan Duggan is currently the Senior Vice President-Operations at TransCode Therapeutics, Inc. She previously worked as the Director-Clinical Affairs at Medtronic Plc and as the Director-Clinical Operations at Samus Therapeutics, Inc. Ms. Duggan completed her undergraduate degree at Colby-Sawyer College and holds an MBA from Rivier University.
She also completed her undergraduate studies at Northern Essex Community College.
Susan Duggan active positions
| Companies | Position | Start |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Chief Operating Officer | - |
Former positions of Susan Duggan
| Companies | Position | End |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Samus Therapeutics, Inc.
 Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Corporate Officer/Principal | - |
Training of Susan Duggan
| Colby-Sawyer College | Undergraduate Degree |
| Rivier University | Masters Business Admin |
| Northern Essex Community College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Stock Market
- Insiders
- Susan Duggan